Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-29T16:29:41.906Z Has data issue: false hasContentIssue false

Ultrastructural Morphology of Cationic Liposome/Dna Complexes for Gene Therapy: Correlation to Transfection Activity

Published online by Cambridge University Press:  02 July 2020

Brigitte Sternberg
Affiliation:
California Pacific Medical Center, Research Institute, San Francisco, California, 94115, USA.
Keelung Hong
Affiliation:
California Pacific Medical Center, Research Institute, San Francisco, California, 94115, USA.
Weiwen Zheng
Affiliation:
California Pacific Medical Center, Research Institute, San Francisco, California, 94115, USA.
Demetrios Papahadjopoulos
Affiliation:
California Pacific Medical Center, Research Institute, San Francisco, California, 94115, USA.
Get access

Extract

Complexes formed during interaction of cationic liposomes with poly-nucleotides such as DNA (CLDC) display a variety of polymorphic and metastable structures. These include multilamellar structures of alternating lipid bilayers and DNA monolayers; fibrillar structures, among them spaghetti-liketubules (Figure 1), and map-pin-structures(Figure 2), and, finally, non-bilayer lipid arrangements, such as hexagonal (HII) (Figure 3) and cubic phases.

In order to find out the “active” structure(s) in terms of transfection, we investigated the transfection activity both in vivoand in vitroof CLDC composed of the lipid DDAB (dimethyl-dioctadecylammonium bromide) and Choi (cholesterol) or DOPE (l,2-dioleoyl-sn-glycerol-3- phosphoethanolamine) as helper lipids. In parallel we studied their morphology by freeze-fracture electron microscopy.The in vivostudies were carried out in mice following i.v. injection and therefore the morphology of the CLDC was investigated in mouse serum.

Type
Biomedical Applications
Copyright
Copyright © Microscopy Society of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Lasic, D. D. et al., J. Amer. Chem. Soc. 119 (1997) 832.CrossRefGoogle Scholar

2. Rädler, J. O. et al., Science 275 (1997) 810.CrossRefGoogle Scholar

3. Steinberg, B. et al., FEBS Lett 356 (1994) 361.CrossRefGoogle Scholar

4. Sternberg, B., J. Liposome Res. 6 (1996) 515.CrossRefGoogle Scholar

5. Sternberg, B., in Lasic, D. D. and Papahadjopoulos, D., Eds., Medical Applications of Liposomes, Amsterdam, Elsevier Science (1998) 395.Google Scholar

6. Sternberg, B. et al., Biochim. Biophys. Acta 1375 (1998) 23.Google Scholar

7. Mok, K. W. C. et al., Biophys. J. 73 (1996) 2534.CrossRefGoogle Scholar

8. Sternberg, B. et al., in Gregoriadis, G. and McCormack, B., Eds.,Targeting of Drugs 6: Strategies for Stealth Therapeutic Systems, New York, Plenum Press (1998)Google Scholar